MARC details
| 000 -LEADER |
|---|
| fixed length control field |
02518nam a2200205Ia 4500 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
NULRC |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20250520094919.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
250520s9999 xx 000 0 und d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
052147020X |
| 040 ## - CATALOGING SOURCE |
|---|
| Transcribing agency |
NULRC |
| 050 ## - LIBRARY OF CONGRESS CALL NUMBER |
|---|
| Classification number |
RA 440.6 .V35 1995 |
| 245 #0 - TITLE STATEMENT |
|---|
| Title |
Valuing health care : |
| Remainder of title |
costs, benefits, and effectiveness of pharmaceuticals and other medical technologies / |
| Statement of responsibility, etc. |
edited by Frank A. Sloan. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. |
|---|
| Place of publication, distribution, etc. |
Cambridge : |
| Name of publisher, distributor, etc. |
Cambridge University Press, |
| Date of publication, distribution, etc. |
c1998 |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
xi, 273 pages : |
| Other physical details |
illustrations ; |
| Dimensions |
22 cm. |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc. note |
Includes bibliographical references and index. |
| 505 ## - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
1. Introduction / Frank A. Sloan -- 2. Evidence of effectiveness: evaluating its quality / Allan S. Detsky -- 3. Utility assessment for estimating quality-adjusted life years / Robert M. Kaplan -- 4. Measuring costs / David Dranove -- 5. From cost-effectiveness ratios to resource allocation: where to draw the line? / Milton C. Weinstein -- 6. Valuing health care benefits in money terms / Mark V. Pauly -- 7. Discounting health effects for medical decisions / W. Kip Viscusi -- 8. Statistical issues in cost-effectiveness analyses / John Mullahy and Willard Manning -- 9. Decision trees and Markov models in cost-effectiveness research / Emmett Keeler -- 10. The use of cost-effectiveness/cost-benefit analysis in actual decision making: current status and prospects / Frank A. Sloan and Christopher J. Conover. |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc. |
As expenditure on health care has increasingly become an area of public debate and concern, public and private health care decision-makers have called for more rigorous use of cost-benefit and cost-effectiveness analysis to guide spending. Concerns have arisen, however, about the overall quality of such analyses. This book discusses and evaluates best-practice methods of conducting cost-benefit and cost-effectiveness studies of pharmaceuticals and other medical technologies. It encompasses a wide variety of topics, ranging from measuring cost and effectiveness to discounting to the use of dynamic modelling of cost-effectiveness. The book also includes conceptual and practical aspects of cost-effectiveness analysis by researchers who have conducted applied research in these areas. Rarely does the book provide a singular solution to a measurement problem; rather, the reader is directed to choices among alternative approaches and an analysis of the advantages and disadvantages of each. |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
MEDICAL CARE -- COST EFFECTIVESS -- RESEARCH -- METHODOLOGY |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
Library of Congress Classification |
| Koha item type |
Books |
